# Two cases of orbital myositis as a rare feature of lyme borreliosis

Arnaud Sauer, Claude Speeg-Schatz, Yves Hansmann

<figure><img src="image_1.png" /></figure>

To cite this version:

Arnaud Sauer, Claude Speeg-Schatz, Yves Hansmann. Two cases of orbital myositis as a rare feature of lyme borreliosis. Case Reports in Infectious Diseases, 2011, 2011 (372470), 10.1155/2011/372470. hal-05259152

HAL Id: hal-05259152

https://univoak.hal.science/hal-05259152v1

Submitted on 15 Sep 2025

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_2.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
Case Report

Two Cases of Orbital Myositis as a Rare Feature of
Lyme Borreliosis

Arnaud Sauer,<fnref n="1" /> Claude Speeg-Schatz,<fnref n="1" /> and Yves Hansmann<fnref n="2" />

Correspondence should be addressed to Arnaud Sauer, arnaud.sauer@chru-strasbourg.fr

Received 16 May 2011; Accepted 15 June 2011

Academic Editors: L. M. Bush, M. du Plessis, and M. Ghate

Copyright © 2011 Arnaud Sauer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Myositis has been reported as a rare manifestation of Lyme disease, and the Lyme disease spirochetes can be an important consideration in the differential diagnosis of unusual cases of myositis, especially in patients who live in or travel to endemic areas. We report the case of two patients who presented with focal orbital myositis which are rare localization for Lyme disease. Myositis were confirmed by magnetic resonance imaging. Diagnosis criteria for *Borrelia burgdorferi* (*B. burgdorferi*) infection was supported by (i) medical history (tick bite in an endemic area), (ii) systemic clinical findings (*Erythema migrans*, neurological manifestation or arthritis), (iii) positive Lyme serology and/or the detection of *B. burgdorferi* DNA by polymerase chain reaction, as well as (iv) exclusion of other infectious and inflammatory causes. The current cases are reviewed in the context of findings from previous myositis descriptions.

**1. Introduction**

Myositis has been reported as a rare manifestation of
Lyme disease, and the Lyme disease spirochetes can be
an important consideration in the differential diagnosis of
unusual cases of myositis, especially in patients who live
in or travel to endemic areas. Lyme borreliosis can also
cause a variety of ocular manifestations (papillary edemas
or abducens palsy are among the most frequent), and the
frequency of these manifestations among cases of Lyme
disease involving systemic manifestations is about 1%. We
report the case of two patients who presented with acute
diplopia and orbital swelling secondary to focal orbital
myositis which are very rare localization for Lyme disease.
Myositis was confirmed by magnetic resonance imaging.
Diagnosis criteria for *Borrelia burgdorferi* (*B. burgdorferi*)
infection were supported by the association of five criterions,
(i) medical history (tick bite in an endemic area), (ii)
systemic clinical findings (*Erythema migrans*, arthritis), (iii)
lab confirmation by positive Lyme serology, (iv) exclusion of
other infectious and inflammatory causes, and (v) efficacy of
specific antibiotherapy. The current cases are reviewed in the
context of findings from previous myositis descriptions.

**2. Cases Report**

We report on the clinical findings in two patients (2 females: 13 and 68 years old) with isolated orbital myositis. The two patients had taken a medical advice for acute unilateral orbital pain and diplopia.

The 68-year-old patient had acute and recurrent episode
(lasting from 2 to 4 weeks, 2 to 4 times each year) of right
orbital swelling and pain since three years. Each episode
resolved spontaneously or with steroids and nonsteroidal
anti-inflammatory drugs. As she complained about a new
episode of orbital swelling complicated with horizontal
diplopia, a complete workup was done. A high intensity
signal on MRI was observed on the right medial rectus
muscle, confirming diagnosis of orbital myositis (Figure 1).
No systemic disease (such as Grave's disease or sarcoïdosis)
or haematological disease or any other infectious disease
was found. As she was living in a rural area of Eastern
France, a highly endemic country for Lyme disease, and
was remembering numerous tick bites and had a history
of *erythema migrans* and arthralgia, Lyme disease was
suspected. Determination of antibodies related to *Borrelia*
was positive. It was decided to begin an antibiotic therapy

<footnote n="1">¹Service d'Ophtalmologie, Hôpitaux Universitaires de Strasbourg, Nouvel Hôpital Civil, BP 426, 67091 Strasbourg Cedex, France</footnote>

<footnote n="2">²Service de Maladies Infectieuses et Tropicales, Hôpitaux Universitaires de Strasbourg,
Nouvel Hôpital Civil, BP 426, 67091 Strasbourg Cedex, France</footnote>
<figure><img src="image_3.png" /><figcaption>FIGURE 1: High signal intensity on MRI images in an orbital myositis related to Lyme disease.</figcaption></figure>

with doxycyclin (200 mg/day), which allowed resolution of ocular and imaging symptoms within 3 weeks. After a followup of 15 years, no relapse of orbital swelling was noted for her.

The 13-year-old woman complained about unilateral orbital swelling complicated with exophtalmia and horizontal diplopia. MRI showed a hyperintense signal of right inferior and medial rectus muscles. Because she was living in the same highly endemic area for Lyme disease and had a recent medical history of tick bite followed by *Erythema migrans*, serologic test for testing the presence of *Borrelia* antibody was rapidly done and was positive. Systemic disease (such as Grave's disease, dysthyroid, or sarcoïdosis) or haematological disease or any other infectious disease was excluded. A 4-week treatment with doxycyclin (200 mg/day) was successful: resolution of ocular symptoms and a decrease of the MRI signal intensity were observed within 1 month. After a 14-month followup, there was no relapse of the disease.

### 3. Discussion

We reported the cases of two patients who presented with orbital myositis caused by *Borrelia* infection at (XXX), which is situated in a highly endemic area for Lyme borreliosis. Diagnosis was done on medical history (tick bite that occurred in an area of endemicity), ocular findings, and systemic clinical findings (*erythema migrans* or arthralgia), as previously published [1, 2].

Systemic disease, such as Grave's disease, or haematological disorders like lymphomas are the principle cause for orbital myositis. In these aetiology, myositis is often bilateral. Infectious diseases, such as staphylococcal septicaemia, may be another cause for unilateral myositis. The aetiologic research for our two patients did not conduct to any of these causes. Only borrelia serology was positive, suggesting the causality of Lyme borreliosis. So, our patients were treated with antibiotics efficient against *Borrelia*. Then, the evolution was absolutely significative, with regression of clinical and radiological signs of myositis in some weeks, without any

anti-inflammatory treatment. Furthermore, for one of the patients, this good evolution under antibiotics treatment occurred even after a long period, whereas corticosteroid therapy did not show any efficacy, arguing for the borrelial origin.

While myalgias are frequently associated with Lyme disease, myositis is a rare manifestation of borrelial infection. Indeed, localized involvement, as in the present cases, is considered to be characteristic of Lyme disease [3]. Borrelial myositis is generally localized to the vicinity of cutaneous lesions [4]. Symptoms and manifestations are protean and include pain, tenderness, swelling, and weakness, as in the present cases. Biological markers such as creatine kinase levels have most often been reported to be normal [3-5]. We have not performed oculomotor muscle biopsy because of the high rate of potential complications and because the aetiological diagnosis was considered as very probable. Moreover, in previous reports, the histopathologic findings were not specific and consisted chiefly of a monocellular, lymphoplasmacytic, and histiocytic infiltrate composed essentially of macrophages and T helper/inducer (CD4+) cells [6].

At present, Lyme borreliosis is diagnosed mainly on the basis of clinical symptoms and serological tests. These tests are based on demonstration in human serum of anti-*B. burgdorferi* s.l. IgG and IgM antibodies and are usually carried out by enzyme-linked immunosorbent assay (ELISA) and Western blot confirmation. Unfortunately, serological tests have a weak sensitivity in presence of *Erythema migrans* (20 to 50%), and, conversely, sensitivity is rising during secondary or tertiary phase between 70 and 90%. However, specificity of a positive serology remains weak because of numerous false positive and crossed reactions with other bacteria [7]. Regarding the multiplicity of ocular manifestations of Lyme disease, the rigorous application of diagnosis criterion is imperious to avoid "excess-diagnosis", as used in former studies [1, 2]: (i) a history of tick bite, (ii) the presence of systemic findings (*erythema migrans*, neurological manifestations, arthritis), (iii) the presence of antibodies related to *Borrelia* species and/or detection
of bacterial DNA by polymerase chain reaction, (iv) the exclusion of other infectious and inflammatory condition, and (v) the efficacy of antibiotics therapy.

Literature features have shown that therapeutic antibiotic regimens were highly varied but usually successful, as in the present cases. These regimens have included treatment with penicillins, cephalosporins, and tetracyclines for durations varying from 10 days to 2 months. Corticosteroids have not infrequently been used as part of the treatment strategy [1, 2, 8, 9].

Orbital myositis is an unusual manifestation of Lyme disease, although it is likely that the condition is underdiagnosed. Unexplained muscle swelling occurring in a patient who has had a rash or a recent history of a tick bite in an endemic area for Lyme disease should prompt consideration of this diagnosis. The diagnosis can usually be made on the basis of clinical features and serologic studies. MRI may be a useful adjunct for diagnosis and followup.

**Disclosure**

The authors have no financial relationships relevant to this paper to disclose.

**References**

[1] A. Sauer, Y. Hansmann, B. Jaulhac, T. Bourcier, and C. Speeg-Schatz, "Five cases of paralytic strabismus as a rare feature of lyme disease," *Clinical Infectious Diseases*, vol. 48, no. 6, pp. 756-759, 2009.

[2] B. Bodaghi, "Ocular manifestations of Lyme disease," *Medecine et Maladies Infectieuses*, vol. 37, no. 7-8, pp. 518-522, 2007.

[3] P. E. Carvounis, A. P. Mehta, and C. E. Geist, "Orbital myositis associated with *Borrelia burgdorferi* (Lyme disease) infection," *Ophthalmology*, vol. 111, no. 5, pp. 1023-1028, 2004.

[4] H. Holak, N. Holak, M. Huzarska, and S. Holak, "Tick inoculation in an eyelid region: report on five cases with one complication of the orbital myositis associated with Lyme borreliosis," *Klinika Oczna*, vol. 108, no. 4-6, pp. 220-224, 2006.

[5] D. Cadavid, Y. Bai, D. Dail et al., "Infection and inflammation in skeletal muscle from nonhuman primates infected with different genospecies of the Lyme disease spirochete *Borrelia burgdorferi*," *Infection and Immunity*, vol. 71, no. 12, pp. 7087-7098, 2003.

[6] A. R. Holmgren and E. L. Matteson, "Lyme myositis," *Arthritis and Rheumatism*, vol. 54, no. 8, pp. 2697-2700, 2006.

[7] M. E. Aguero-Rosenfeld, G. Wang, I. Schwartz, and G. P. Wormser, "Diagnosis of Lyme borreliosis," *Clinical Microbiology Reviews*, vol. 18, no. 3, pp. 484-509, 2005.

[8] C. D. Reimers, J. de Koning, U. Neubert et al., "Borrelia burgdorferi myositis: report of eight patients," *Journal of Neurology*, vol. 240, no. 5, pp. 278-283, 1993.

[9] H. O. Mikkilä, I. J. T. Seppälä, M. K. Viljanen, M. P. Peltomaa, and A. Karma, "The expanding clinical spectrum of ocular lyme borreliosis," *Ophthalmology*, vol. 107, no. 3, pp. 581-587, 2000.
<figure><img src="image_4.png" /></figure>

<figure><img src="image_5.png" /></figure>

<figure><img src="image_6.png" /></figure>

<figure><img src="image_7.png" /></figure>

<figure><img src="image_8.png" /></figure>

<figure><img src="image_9.png" /></figure>

<figure><img src="image_10.png" /></figure>

<figure><img src="image_11.png" /></figure>

<figure><img src="image_12.png" /></figure>

<figure><img src="image_13.png" /></figure>

<figure><img src="image_14.png" /></figure>

<figure><img src="image_15.png" /></figure>

Hindawi

Submit your manuscripts at
http://www.hindawi.com

<figure><img src="image_16.png" /></figure>

<figure><img src="image_17.png" /></figure>

<figure><img src="image_18.png" /></figure>

<figure><img src="image_19.png" /></figure>

CAM

<figure><img src="image_20.png" /></figure>

<figure><img src="image_21.png" /></figure>

<figure><img src="image_22.png" /></figure>

Evidence-Based
Complementary and
Alternative Medicine

<figure><img src="image_23.png" /></figure>

Journal of
Oncology

<figure><img src="image_24.png" /></figure>

Oxidative Medicine and
Cellular Longevity

BioMed
Research International

International Journal of
Endocrinology

Endocrine Metabolism & Cell Signaling

Disease Markers

<figure><img src="image_25.png" /></figure>

<figure><img src="image_26.png" /></figure>